DAI-ICHI Life Insurance is eyeing its friendly $1.76 billion move on Tower Australia as a beachhead for further expansion into the Asian life insurance market.
The takeover has turned out to be a goldmine for Tower's chief executive, Jim Minto, who is on track to make $34 million from the deal. The payment forms the rump of $70 million Dai-ichi has promised to buy the outstanding stock options held by six of Tower's senior management.
Dai-ichi has promised to retain Tower's Australian board and management, including Mr Minto. It is expected to pursue more wealth management acquisitions.
Tower shares surged to a record high after its independent directors unanimously recommended the takeover bid by Dai-ichi, its 29 per cent shareholder, subject to the offer being deemed fair and reasonable by an independent expert.
The Tower takeover follows a string of wealth management acquisitions, including AMP's friendly $13.3 billion move on its rival AXA Asia Pacific.
Analysts warned that a reinvigorated Tower could compete with major players like National Australia Bank and AMP as they battle for dominance in the life insurance market. Tower is Australia's fifth-biggest life insurer, measured on sales.
Dai-ichi's offer of $4 cash for each Tower share represents a 46 per cent premium, based on Tower's average trading price of the past month. Tower closed at $3.87 yesterday, up 42 per cent.
The offer amounts to 1.4 times Tower's embedded value and 19.1 times forward earnings, a slight premium to comparable transactions, including NAB's buyout of Aviva.
Tower's shares have been under pressure in recent months amid uncertainty about how much capital would need to be pumped into the business following new regulations mostly designed to strengthen the financial system.
"In this regard, Dai-ichi's approach looks to be well-timed," an insurance analyst with Goldman Sachs, Ryan Fisher, said.
Talks between Tower and Dai-ichi have been taking place since mid-December, with much of the negotiations coming down to pricing. A scheme implementation agreement was signed late Tuesday night.
Tower's chairman, Rob Thomas, said the company's independent directors considered the offer represented a "compelling premium and a highly attractive" outcome for shareholders.
The deal is subject to Australian and Japanese regulatory approvals. A Tower shareholders' meeting to vote on the offer is likely to be held in the second quarter of the new year.
Frequently Asked Questions about this Article…
What is Dai-ichi Life Insurance’s takeover bid for Tower Australia?
Dai-ichi Life Insurance has made a friendly takeover bid to buy Tower Australia for about $1.76 billion. The offer is $4 cash for each Tower share and was recommended unanimously by Tower’s independent directors, subject to an independent expert deeming the offer fair and reasonable.
How much of a premium does Dai-ichi’s $4-per-share offer represent for Tower shareholders?
Dai-ichi’s $4 cash offer represents roughly a 46% premium based on Tower’s average trading price over the past month. Tower shares closed at $3.87 the day before the announcement, up about 42%.
What valuation multiples are implied by the Dai-ichi offer for Tower?
The $4-per-share offer amounts to about 1.4 times Tower’s embedded value and roughly 19.1 times forward earnings, which the article describes as a slight premium to comparable deals in the sector.
Will Tower’s management and board stay on after the Dai-ichi takeover?
Yes. Dai-ichi has promised to retain Tower’s Australian board and management, including chief executive Jim Minto. The deal also includes a package to buy outstanding stock options held by six senior managers, with Minto set to receive around $34 million from the transaction.
Why is Dai-ichi buying Tower Australia — what’s the strategic reason?
Dai-ichi is treating the Tower acquisition as a beachhead for further expansion into the Asian life insurance market. The company is also expected to pursue additional wealth management acquisitions as part of its broader strategy.
How might the takeover change competition in the Australian life insurance market?
Analysts say a reinvigorated Tower could compete more strongly with major players such as National Australia Bank and AMP, intensifying competition as firms battle for dominance in the life insurance market. Tower is currently Australia’s fifth-biggest life insurer by sales.
What approvals and next steps are required before the Dai-ichi-Tower deal is completed?
The deal is subject to Australian and Japanese regulatory approvals and must be deemed fair and reasonable by an independent expert. A scheme implementation agreement was signed, and a Tower shareholders’ meeting to vote on the offer is likely to be held in the second quarter of the new year.
What should everyday investors know about the impact of the offer on Tower shareholders?
For Tower shareholders, the $4-per-share cash offer provides a substantial premium to recent trading prices and was described by Tower’s independent directors as a compelling and highly attractive outcome. Investors should note the deal still needs regulatory sign-off and shareholder approval before it is finalized.